SCOPUS 정보 검색 플랫폼

Oncology

Volumn 62, Issue SUPPL. 1, 2002, Pages 87-93

Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C

(2) Hayashi, Norio a Kasahara, Akinori a

a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE (Japan)

Author keywords

Hepatitis C virus; Hepatitis, chronic; Hepatocellular carcinoma; Interferon; Liver cirrhosis

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON;

AMINOTRANSFERASE BLOOD LEVEL; CANCER INCIDENCE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; GENE LOSS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; LIVER NEOPLASMS; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0036294410 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000048282 Document Type: Conference Paper

Times cited : (6)

References (43)

1
- 0028297985
- Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels
- (1994) Hepatology , vol.19 , pp. 871-875
- Naito, M.¹ Hayashi, N.² Hagiwara, H.³ Hiramatsu, N.⁴ Kasahara, A.⁵ Fusamoto, H.⁶ Kamada, T.⁷

2
- 0031891214
- Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: A pilot randomized controlled study
- (1998) Hepatology , vol.27 , pp. 853-856
- Sangiovanni, A.¹ Morales, R.² Spinzi, G.³ Rumi, M.⁴ Casiraghi, A.⁵ Ceriani, R.⁶ Colombo, E.⁷ Fossati, M.⁸ Prada, A.⁹ Travani, E.¹⁰ Minoli, G.¹¹

3
- 0024368522
- Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial
- (1989) N Engl J Med , vol.321 , pp. 1501-1506
- Davis, G.L.¹ Balart, L.A.² Schiff, E.R.³ Lindsay, K.⁴ Bodenheimer, H.C.⁵ Perrillo, R.P.⁶ Carey, W.⁷ Jacobson, I.M.⁸ Payne, J.⁹ Dienstag, J.L.¹⁰ Van Thiel, D.H.¹¹ Tamburro, C.¹² Lefkowitch, J.¹³ Albrecht, J.¹⁴ Meschievitz, C.¹⁵ Oretego, T.J.¹⁶

4
- 0024981607
- Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double blind placebo-controlled trial
- (1989) N Engl J Med , vol.321 , pp. 1506-1510
- Di Bisceglie, A.M.¹ Martin, P.² Kassianides, C.³ Lisker-Melman, M.⁴ Murray, L.⁵ Waggoner, J.⁶ Goodman, Z.⁷ Banks, S.M.⁸ Hoofnagle, J.H.⁹

5
- 0027404908
- Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
- (1993) Gastroenterology , vol.104 , pp. 877-883
- Hagiwara, H.¹ Hayashi, N.² Mita, E.³ Takehara, T.⁴ Kasahara, A.⁵ Fusamoto, H.⁶ Kamada, T.⁷

6
- 0028937539
- Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial
- (1995) Hepatology , vol.21 , pp. 291-297
- Kasahara, A.¹ Hayashi, N.² Hiramatsu, N.³ Oshita, M.⁴ Hagiwara, H.⁵ Katayama, K.⁶ Kato, M.⁷ Masuzawa, M.⁸ Yoshihara, H.⁹ Kishida, Y.¹⁰ Shimizu, Y.¹¹ Inoue, A.¹² Fusamaoto, H.¹³ Kamada, T.¹⁴

7
- 0028970295
- Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha
- (1995) J Hepatol , vol.22 , pp. 135-142
- Hiramatsu, N.¹ Hayashi, N.² Kasahara, A.³ Hagiwara, H.⁴ Takehara, T.⁵ Haruna, Y.⁶ Naito, M.⁷ Fusamoto, H.⁸ Kamada, T.⁹

8
- 0345416844
- Therapy of hepatitis C. Meta-analysis of interferon alfa-2b trials
- (1997) Hepatology , vol.26
- Carithers R.L., Jr.¹ Emerson, S.S.²

9
- 0025768539
- Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis
- (1991) Gastroenterology , vol.101 , pp. 497-502
- Causse, X.¹ Godinot, H.² Chevallier, M.³ Chossegros, P.⁴ Zoulim Ouzan, D.⁵ Heyraud, J.P.⁶ Fontages, T.⁷ Albrecht, J.⁸ Meschievitz, C.⁹ Trepo, C.¹⁰

10
- 0029833829
- Meta-analysis of interferon randomized trials in the treatment of viral hepatitis: Effects of dose and duration
- (1996) Hepatology , vol.24 , pp. 778-789
- Poynard, T.¹ Leroy, V.² Cohard, M.³ Thevenot, T.⁴ Mathurin, P.⁵ Opolon, P.⁶ Zarski, J.P.⁷

11
- 0030317884
- Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-α in chronic hepatitis C
- (1996) Ann Intern Med , vol.124 , pp. 1058-1060
- Chemello, L.¹ Cavaletto, L.² Casarin, C.³ Bonetti, P.⁴ Bernardinello, E.⁵ Pontisso, P.⁶ Donada, C.⁷ Belussi, F.⁸ Martinelli, S.⁹ Alberti, A.¹⁰

12
- 0029054011
- A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis
- Multicenter Study Group
- (1995) N Engl J Med , vol.332 , pp. 1457-1462
- Poynard, T.¹ Bedossa, P.² Chevallier, M.³ Mathurin, P.⁴ Lemonnier, C.⁵ Trepo, C.⁶ Couzigou, P.⁷ Payen, J.L.⁸ Sajus, M.⁹ Costa, J.M.¹⁰

13
- 0028864271
- Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates. Results of the first multicenter Australian trial
- Australia Hepatitis C Study Group
- (1995) J Hepatol , vol.23 , pp. 487-496
- Lin, R.¹ Roach, E.² Zimmerman, M.³ Strasser, S.⁴ Farrell, G.C.⁵

14
- 0030744369
- Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis C. Results of a multicenter randomized trial
- (1997) J Hepatol , vol.27 , pp. 56-62
- Saracco, G.¹ Borghesio, E.² Mesina, P.³ Solinas, A.⁴ Spezia, C.⁵ Macor, F.⁶ Gallo, V.⁷ Chiandussi, L.⁸ Donada, C.⁹ Donadon, V.¹⁰ Spirito, F.¹¹ Mangia, A.¹² Andriulli, A.¹³ Verme, G.¹⁴ Rizzetto, M.¹⁵

15
- 0028239921
- Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer
- (1994) Dig Dis Sci , vol.39 , pp. 977-982
- Mita, E.¹ Hayashi, N.² Hagiwara, H.³ Ueda, K.⁴ Kanazawa, Y.⁵ Kasahara, A.⁶ Fusamto, H.⁷ Kamada, T.⁸

16
- 0026734297
- Detection of hepatitis C virus by polymerase chain reaction and response to interferon therapy: Relationship to genotypes of hepatitis C virus
- (1992) Hepatology , vol.16 , pp. 293-299
- Yoshioka, K.¹ Kakumu, S.² Wakita, T.³ Ishikawa, T.⁴ Itoh, Y.⁵ Takayanagi, M.⁶ Higashi, Y.⁷ Shibata, M.⁸ Morishima, T.⁹

17
- 7144260399
- Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon
- (1998) J Gastroenterol Hepatol , vol.13 , pp. 412-418
- Fukuda, M.¹ Chayama, K.² Tsubota, A.³ Kobayashi, M.⁴ Hashimoto, M.⁵ Miyano, Y.⁶ Koike, H.⁷ Koida, I.⁸ Arase, Y.⁹ Saitoh, S.¹⁰ Murashima, N.¹¹ Ikeda, K.¹² Kumada, H.¹³

18
- 0028987904
- Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C
- (1995) J Hepatol , vol.22 , pp. 457-463
- Yuki, N.¹ Hayashi, N.² Kasahara, A.³ Hagiwara, H.⁴ Takehara, T.⁵ Oshita, M.⁶ Katayama, K.⁷ Fusamoto, H.⁸ Kamada, T.⁹

19
- 0026772470
- Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon
- (1992) Hepatology , vol.15 , pp. 1013-1016
- Shindo, M.¹ Di Bisceglie, A.M.² Hoofnagle, J.H.³

20
- 0027441113
- Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C
- (1993) Lancet , vol.342 , pp. 1208-1209
- Lau, J.Y.N.¹ Mizokami, M.² Ohno, T.³ Diamond, D.A.⁴ Kniffen, J.⁵ Davis, G.L.⁶

21
- 17344369924
- Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
- (1998) Hepatology , vol.27 , pp. 1394-1402
- Kasahara, A.¹ Hayashi, N.² Mochizuki, K.³ Takayanagi, M.⁴ Yoshroka, K.⁵ Kakumu, S.⁶ Iijima, A.⁷ Urushihara, A.⁸ Kiyosawa, K.⁹ Okuda, M.¹⁰ Hino, K.¹¹ Okita, K.¹²

22
- 0029024672
- Serial density analysis of hepatitis C virus particle populations in chronic hepatitis C patients treated with interferon-alpha
- (1995) J Med Virol , vol.46 , pp. 230-237
- Kanto, T.¹ Hayashi, N.² Takehara, T.³ Hagiwara, H.⁴ Mita, E.⁵ Oshita, M.⁶ Katayama, K.⁷ Kasahara, A.⁸ Fusamoto, H.⁹ Kamada, T.¹⁰

23
- 0027438330
- Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-a2b
- (1993) Hepatology , vol.18 , pp. 1300-1305
- Saracco, G.¹ Rosina, F.² Abate, M.L.³ Chiandussi, L.⁴ Gallo, V.⁵ Cerutti, E.⁶ Di Napoli, A.⁷ Solinas, A.⁸ Deplano, A.⁹ Tocco, A.¹⁰ Cossu, P.¹¹ Chien, D.¹² Kuo, G.¹³ Polito, A.¹⁴ Weiner, A.J.¹⁵ Houghton, M.¹⁶ Verme, G.¹⁷ Bonino, F.¹⁸ Rizzetto, M.¹⁹

24
- 0019813866
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
- (1981) Hepatology , vol.1 , pp. 431-435
- Knodell, R.G.¹ Ishak, K.G.² Black, W.C.³ Chen, T.S.⁴ Craig, R.⁵ Kaplowitz, N.⁶ Kiernan, T.W.⁷ Wollman, J.⁸

25
- 0027491648
- Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation
- (1993) Hepatology , vol.18 , pp. 1344-1349
- Manabe, N.¹ Chevallier, M.² Chossegros, P.³ Causse, X.⁴ Guerret, S.⁵ Trepo, C.⁶ Grimaud, J.A.⁷

26
- 0032905640
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
- (1999) Gastroenterology , vol.116 , pp. 378-386
- Sobesky, R.¹ Mathurin, P.² Charlotte, F.³ Moussalli, J.⁴ Olivi, M.⁵ Vidaud, M.⁶ Ratziu, V.⁷ Opolon, P.⁸ Pyonard, T.⁹

27
- 0031704927
- 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C
- (1998) Hepatology , vol.28 , pp. 1121-1127
- Lau, D.T.L.¹ Kleiner, D.E.² Ghany, M.G.³ Park, Y.⁴ Schmid, P.⁵ Hoofnagle, J.H.⁶

28
- 0032124863
- Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: Quantitative assessment by a morphometric method
- (1998) J Hepatol , vol.29 , pp. 20-28
- Duchatelle, V.¹ Marcellin, P.² Giostra, E.³ Bregeaud, L.⁴ Pouteau, M.⁵ Boyer, N.⁶ Auperin, A.⁷ Guerret, S.⁸ Erlinger, S.⁹ Henin, D.¹⁰ Degott, C.¹¹

29
- 2442724379
- Transforming growth factor-beta modulates the expression of collagenase and metalloproteinase inhibitor
- (1987) EMBO J , vol.6 , pp. 1899-1904
- Edwards, D.R.¹ Murphy, G.² Reynolds, J.J.³ Whitham, S.E.⁴ Docherty, A.J.⁵ Angel, P.⁶ Heath, J.K.⁷

30
- 0028953768
- Hepatic expression of transforming growth factor-beta 1 in transgenic mice results in multiple tissue lesions
- (1995) Proc Natl Acad Sci USA , vol.92 , pp. 2572-5276
- Sanderson, N.¹ Factor, V.² Nagy, P.³ Kopp, J.⁴ Kondaiah, P.⁵ Wakefield, L.⁶ Roberts, A.B.⁷ Sporn, M.B.⁸ Thorgeirsson, S.S.⁹

31
- 0025855367
- Transforming growth factor beta 1 and alpha in chronic liver disease: Effects of interferon alfa therapy
- (1991) N Engl J Med , vol.324 , pp. 933-940
- Castilla, A.¹ Prieto, J.² Fausto, N.³

32
- 0032955814
- Reduced plasma transforming growth-factor-β1 levels in patients with chronic hepatitis C after interferon-alpha therapy: Association with regression of hepatic fibrosis
- (1999) J Hepatol , vol.30 , pp. 1-7
- Tsushima, H.¹ Kawata, S.² Tamura, S.³ Ito, N.⁴ Shirai, Y.⁵ Kiso, S.⁶ Doi, Y.⁷ Yamada, A.⁸ Oshikawa, O.⁹ Matsuzawa, Y.¹⁰

33
- 0033082888
- Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy
- (1999) Am J Gastroenterol , vol.94 , pp. 489-496
- Sakaida, I.¹ Nagatomi, A.² Hironaka, K.³ Uchida, K.⁴ Okita, K.⁵

34
- 0343111507
- Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C
- (1998) Ann Intern Med , vol.129 , pp. 94-99
- Imai, Y.¹ Kawata, S.² Tamura, S.³ Yabuuchi, I.⁴ Noda, S.⁵ Inada, M.⁶ Maeda, Y.⁷ Shirai, Y.⁸ Fukuzaki, T.⁹ Kaji, I.¹⁰ Ishikawa, H.¹¹ Matsuda, Y.¹² Nishikawa, M.¹³ Seki, K.¹⁴ Matsuzawa, Y.¹⁵

35
- 0032898360
- Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis
- (1999) Hepatology , vol.29 , pp. 1124-1130
- Ikeda, K.¹ Saitoh, S.² Arase, Y.³ Chayama, K.⁴ Suzuki, Y.⁵ Kobayashi, M.⁶ Tsubota, A.⁷ Nakamura, I.⁸ Murashima, N.⁹ Kumada, H.¹⁰ Kawanishi, M.¹¹

36
- 0033520109
- Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan
- (1999) Ann Intern Med , vol.131 , pp. 174-181
- Yoshida, H.¹ Shiratori, Y.² Moriyama, M.³ Arakawa, Y.⁴ Ide, T.⁵ Sata, M.⁶ Inoue, O.⁷ Yano, M.⁸ Tanaka, M.⁹ Fujiyama, S.¹⁰ Nishiguchi, S.¹¹ Kuroki, T.¹² Imazeki, F.¹³ Yokosuka, O.¹⁴ Kinoyama, S.¹⁵ Yamada, G.¹⁶ Omata, M.¹⁷

37
- 0028876371
- Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis
- (1995) Lancet , vol.346 , pp. 1051-1055
- Nishiguchi, S.¹ Kuroki, T.² Nakatani, S.³ Moriomoto, H.⁴ Takeda, T.⁵ Nakajima, S.⁶ Shiomi, S.⁷ Seki, S.⁸ Kobayashi, K.⁹ Otani, S.¹⁰

38
- 0032997086
- Treatment of hepatitis C virus-related cirrhosis: A randomized, controlled trial of interferon alfa-2b versus no treatment
- (1999) Hepatology , vol.29 , pp. 1870-1875
- Valla, D.C.¹ Chevallier, M.² Marcellin, P.³ Payen, J.L.⁴ Trepo, C.⁵ Fonck, M.⁶ Bourliere, M.⁷ Boucher, E.⁸ Miguet, J.P.⁹ Parlier, D.¹⁰ Lemonnier, C.¹¹ Opolon, P.¹²

39
- 0030020455
- Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
- (1996) J Hepatol , vol.24 , pp. 14-47
- Mazzella, G.¹ Accogli, E.² Sottili, S.³ Festi, D.⁴ Orsini, M.⁵ Salzetta, A.⁶ Novelli, V.⁷ Cipolla, A.⁸ Fabbri, C.⁹ Pezzoli, A.¹⁰ Roda, E.¹¹

40
- 0030744373
- Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis
- (1997) J Hepatol , vol.27 , pp. 201-205
- Fattovich, G.¹ Giustina, G.² Degos, F.³ Diodati, G.⁴ Tremolada, F.⁵ Nevens, F.⁶ Almasio, P.⁷ Solinas, A.⁸ Brouwer, J.T.⁹ Thomas, H.¹⁰ Realdi, G.¹¹ Corrocher, R.¹² Schalm, S.W.¹³

41
- 0032560376
- Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: A retrospective cohort study
- (1998) Lancet , vol.351 , pp. 1535-1539
- Brunetto, M.R.¹ Oliveri, F.² Koehler, M.³ Zahm, F.⁴ Bonino, F.⁵

42
- 0031960043
- Determinants of outcome of compensated hepatitis C virus-related cirrhosis
- (1998) Hepatology , vol.27 , pp. 1435-1440
- Serfaty, L.¹ Aumaitre, H.² Chazouilleres, O.³ Bonnand, A.M.⁴ Rosmorduc, O.⁵ Poupon, R.E.⁶ Poupon, R.⁷

43
- 0032996855
- Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in advanced stage: A retrospective study in 1148 patients
- (1999) J Hepatol , vol.30 , pp. 653-659
- Okanoue, T.¹ Itoh, Y.² Minami, M.³ Sakamoto, S.⁴ Yasui, K.⁵ Sakamoto, M.⁶ Nishioji, K.⁷ Murakami, Y.⁸ Kashima, K.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.